UAP1

Chr 1

UDP-N-acetylglucosamine pyrophosphorylase 1

Also known as: AGX, AGX1, AGX2, SPAG2

Enables identical protein binding activity and protein serine pyrophosphorylase activity. Involved in antiviral innate immune response and positive regulation of type I interferon production. Is active in cytosol. [provided by Alliance of Genome Resources, Jun 2026]

OMIMResearchGenerating clinical summary…

Clinical highlights

Interpreting a novel variant
This gene is strongly intolerant of loss-of-function variation in the population, so LoF variants warrant close attention. No curated mechanism annotation is available — see the mechanism card for the computational prediction and its caveats.Based on population constraint only.
0
Active trials
14
Pubs (1 yr)
P/LP submissions
P/LP missense
0.54
LOEUF
Mechanism

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint?
0.54LOEUF
pLI 0.023
Z-score 3.37
OE 0.30 (0.170.54)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?
1.02Z-score
OE missense 0.83 (0.740.92)
226 obs / 273.7 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.30 (0.170.54)
00.351.4
Missense OE?0.83 (0.740.92)
00.61.4
Synonymous OE?1.20
01.21.6
LoF obs/exp: 8 / 26.8Missense obs/exp: 226 / 273.7Syn Z: -1.48

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

UAP1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →